Unique ID issued by UMIN | UMIN000011510 |
---|---|
Receipt number | R000013466 |
Scientific Title | Association of the use of vitamin D receptor activators with incident cardiovascular disease and death after it in hemodialysis patients |
Date of disclosure of the study information | 2013/10/10 |
Last modified on | 2014/09/01 14:42:53 |
Association of the use of vitamin D receptor activators with incident cardiovascular disease and death after it in hemodialysis patients
Association of the use of vitamin D receptor activators with incident cardiovascular disease and death after it in hemodialysis patients
Association of the use of vitamin D receptor activators with incident cardiovascular disease and death after it in hemodialysis patients
Association of the use of vitamin D receptor activators with incident cardiovascular disease and death after it in hemodialysis patients
Japan |
Hemodialysis patients
Cardiology | Endocrinology and Metabolism | Nephrology |
Others
NO
To examine whether the use of vitamin D receptor activators (VDRAs) predicts incident cardiovascular disease (CVD) and death after CVD
Others
To examine associations of other CKD-MBD-related factors with incident CVD and death after CVD
1) Incident CVD (composite of myocardial infarction, cerebral infarction and cerebral bleeding)
2) Death after CVD
Observational
20 | years-old | <= |
90 | years-old | >= |
Male and Female
Prevalent hemodialysis patients at the end of 2004,
1) receiving thrice weekly hemodialysis
2) age between 20 and 90 years old
3) No previous history of myocardial infarction, cerebral infarction or cerebral bleeding
The subjects are excluded if any of the following data is unavailable;
1) the use/nonuse of VDRAs, age, sex, dialysis vintage, underlying kidney disease (diabetic or not), serum calcium, phosphate, intact PTH, albumin, CRP and body mass index at the end of 2004.
2) Information of past history of myocardial infarction, cerebral infarction or cerebral bleeding, and vital state (if dead, the cause of death) at the end of 2005.
49659
1st name | |
Middle name | |
Last name | Tetsuo Shoji |
Japanese Society for Dialysis Therapy (JSDT)
Committee of Renal Data Registry
2-38-21, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
03-5800-0790
t-shoji@med.osaka-cu.ac.jp
1st name | |
Middle name | |
Last name | Tetsuo Shoji |
Osaka City University Graduate School of Medicine
Department of Geriatrics and Vascular Medicine
1-4-3, Asahi-machi, Abeno-ku, Osaka 545-8585, Japan
06-6645-3930
t-shoji@med.osaka-cu.ac.jp
Japanese Society for Dialysis Therapy, Committee of Renal Data Registry (JSTD-CRDR)
Self funding
Self funding
NO
2013 | Year | 10 | Month | 10 | Day |
Partially published
Completed
2011 | Year | 01 | Month | 01 | Day |
2011 | Year | 01 | Month | 01 | Day |
We extracted 49,659 hemodialysis patients at the end of 2004. VDRAs were used in 57% of the subjects at baseline. We identified 3134 patients with incident CVD and 373 deaths after the events. The use of VDRAs was an independent predictors of lower risk of incident CVD, but not a risk factor of death after CVD.
2013 | Year | 08 | Month | 18 | Day |
2014 | Year | 09 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013466
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |